Susquehanna International Group, LLP Alterity Therapeutics LTD Transaction History

Susquehanna International Group, LLP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.01 - $0.02 $103 - $207	-10,352 Reduced 32.47%	21,532 $13,000
Q1 2022 May 16, 2022	SELL	$0.01 - $0.02 $297 - $594	-29,701 Reduced 48.23%	31,884 $26,000
Q4 2021 Feb 14, 2022	BUY	$0.01 - $0.02 $615 - $1,231	61,585 New	61,585 $44,000
Q3 2019 Nov 14, 2019	SELL	$0.0 - $0.02 $0 - $229	-11,451 Closed	0 $0
Q2 2019 Nov 14, 2019	BUY	$0.0 - $0.03 $0 - $343	11,451 New	11,451 $15,000

Ticker ATHE
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 40,114,600
Market Cap $86.2M
Description
Alterity Therapeutics Limited engages in the research and development of therapeutic drugs to treat Alzheimer's disease, Huntington disease, Parkinson's disease, and other neurological disorders in Australia. The company's lead drug candidate is ATH434 that has completed Phase I clinical trial for the treatment of Parkinson's disease. It is also...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.